The impact of proton pump inhibitor exposure on survival outcomes with zolbetuximab

Akihiro Yamada et al.

Avacincaptad pegol for GA: 3-year results from the GATHER2 open-label extension trial
zolbemicrosite-unbranded-north-america-global-en-banner-mobile.png

Graphical abstract

Presentation content summarized in plain language